Apollo Hospitals Enterprise Sees Sharp Open Interest Surge Amid Rising Market Momentum

Open Interest and Volume Dynamics

The latest data reveals that Apollo Hospitals’ open interest (OI) in derivatives has climbed sharply to 45,326 contracts, up by 4,781 contracts or 11.79% from the previous figure of 40,545. This substantial increase in OI is complemented by a robust trading volume of 84,424 contracts, indicating heightened activity and investor engagement in the stock’s futures and options market.

In monetary terms, the futures segment alone accounted for a value of approximately ₹53,613.63 lakhs, while the options segment exhibited an extraordinary notional value of ₹74,527.09 crores. The combined derivatives turnover thus stands at nearly ₹62,997.82 lakhs, underscoring the stock’s liquidity and attractiveness to traders.

Price Performance and Market Context

Apollo Hospitals has outperformed its sector peers, registering a 1.49% gain on the day, which is 1.06% higher than the hospital sector’s 0.20% rise. The stock has also delivered a 5.08% return over the past two consecutive trading sessions, reflecting sustained buying interest. Notably, the stock’s price currently trades above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains slightly below the 100-day moving average, suggesting a strong short- to medium-term uptrend with some resistance at longer-term levels.

Investor participation has surged, with delivery volumes reaching 2.93 lakh shares on 6 January 2026, marking a 51.81% increase compared to the five-day average delivery volume. This rise in delivery volume indicates genuine accumulation rather than speculative trading, reinforcing the bullish narrative.

Market Capitalisation and Quality Metrics

Apollo Hospitals Enterprise Ltd. is a large-cap stock with a market capitalisation of ₹1,06,918 crore, classified under the hospital industry and sector. The company’s Mojo Score stands at a robust 71.0, reflecting a strong buy rating, upgraded from a previous hold rating as of 1 January 2026. The market cap grade is rated as 1, indicating top-tier market capitalisation and liquidity.

Such upgrades in quality grades and scores often attract institutional investors and momentum traders, further amplifying the stock’s appeal in the derivatives market.

Directional Bets and Market Positioning

The surge in open interest alongside rising volumes suggests that market participants are positioning for a potential upward move in Apollo Hospitals’ stock price. The increase in futures value to ₹53,613.63 lakhs indicates strong long positioning, while the sizeable options notional value points to active hedging and speculative strategies.

Given the stock’s recent outperformance relative to the sector and the Sensex — which declined by 0.30% on the same day — investors appear confident in Apollo Hospitals’ growth prospects and resilience amid broader market uncertainties. The stock’s liquidity, sufficient to support trade sizes of up to ₹4.67 crore based on 2% of the five-day average traded value, further facilitates large institutional trades and derivative strategies.

Technical and Fundamental Outlook

Technically, the stock’s position above key moving averages signals a positive momentum trajectory, although the resistance near the 100-day moving average warrants caution. The rising delivery volumes and upgraded Mojo Grade from Hold to Buy reinforce the fundamental strength underpinning the stock.

Investors should note that while the open interest increase is a bullish indicator, it also reflects heightened volatility and the potential for rapid price swings. Monitoring the balance between call and put options, as well as futures positioning, will be crucial to gauge the sustainability of this trend.

Implications for Investors

For investors, the current open interest surge in Apollo Hospitals’ derivatives market signals a window of opportunity to capitalise on the stock’s upward momentum. The combination of strong fundamentals, improved market sentiment, and technical strength provides a compelling case for accumulation.

However, given the stock’s large-cap status and sector dynamics, investors should remain vigilant to sector-specific risks such as regulatory changes, healthcare policy shifts, and macroeconomic factors impacting hospital operations. Diversification and risk management remain key considerations.

Overall, the upgraded Mojo Grade to Buy and the positive price action relative to sector and benchmark indices suggest that Apollo Hospitals is well-positioned to deliver value in the near to medium term.

Conclusion

The recent spike in open interest and volume in Apollo Hospitals Enterprise Ltd.’s derivatives market reflects a growing bullish consensus among investors. Supported by strong price performance, rising delivery volumes, and an upgraded quality rating, the stock is attracting increased attention from both institutional and retail participants.

While the technical indicators and market positioning point towards further gains, investors should continue to monitor evolving market conditions and derivative activity to optimise their strategies. Apollo Hospitals remains a key large-cap player in the hospital sector, combining solid fundamentals with active market interest, making it a stock to watch closely in 2026.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →